Joseph L Goldstein Net Worth & Insider Trades

Joseph L Goldstein - Director, Regeneron Pharmaceuticals, Inc

As of April 1, 2022

What is Joseph L Goldstein's Net Worth?

The current estimated net worth of Regeneron Pharmaceuticals, Inc's Director, Joseph L Goldstein, is estimated to be about $75.01M . Joseph L Goldstein owns about 6,082 units of Regeneron Pharmaceuticals, Inc common stock. In the last 19 years at Regeneron Pharmaceuticals, Inc, Joseph L Goldstein has sold an estimated value of $66.64M worth.

What is Joseph L Goldstein's Past Insider Trading?

Joseph L Goldstein's largest purchase order was 16,574 units , worth over $6.24M on September 23, 2020. Joseph L Goldstein's largest sale order was 16,574 units , worth over $9.11M on September 23, 2020. In total, Joseph L Goldstein has made about 95 transactions over 19 years of their time at Regeneron Pharmaceuticals, Inc. Joseph L Goldstein usually trades in January, with the busiest year in 2020, 2013 and 2014. The most recent transaction was a sale order of 2,431 units , worth over $1.7M on April 1, 2022.

Joseph L Goldstein

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Joseph L Goldstein's' Mailing Address?

  • Mailing address is Dept of Pharmacology K5 Yuver of Texas 5323 Harry Hines Blvd Dallas TX 75390 TX

Regeneron Pharmaceuticals, Inc Executive Compensation

Name
Year
Salary
Stock Awards
Other Earnings Plans or Compensations
Other Earnings Plans or Compensations
Other Compensation
Total
Leonard S. Schleifer, M.D., Ph.D. 2020 $1,480,119 $130,000,032 $3,567,714 $3,567,714 $302,256 $135,350,121
Leonard S. Schleifer, M.D., Ph.D. 2019 $1,377,100 $4,983,226 $3,057,162 $3,057,162 $338,043 $21,455,117
Leonard S. Schleifer, M.D., Ph.D. 2018 $1,330,500 - $2,953,710 $2,953,710 $896,432 $26,520,555
George D. Yancopoulos, M.D., Ph.D. 2020 $1,258,096 $130,000,032 $3,004,391 $3,004,391 $120,800 $134,383,319
George D. Yancopoulos, M.D., Ph.D. 2019 $1,170,500 $4,983,226 $2,598,510 $2,598,510 $212,313 $20,664,135
George D. Yancopoulos, M.D., Ph.D. 2018 $1,130,900 - $2,510,598 $2,510,598 $399,718 $25,381,129
Robert E. Landry 2020 $825,577 $949,560 $938,872 $938,872 $24,195 $6,197,703
Robert E. Landry 2019 $730,000 $2,840,008 $811,395 $811,395 $23,470 $7,931,542
Robert E. Landry 2018 $680,000 $4,767,500 $581,400 $581,400 $19,535 $9,356,619
Daniel P. Van Plew 2020 $825,577 $3,409,560 $938,872 $938,872 $20,945 $8,654,453
Daniel P. Van Plew 2019 $683,100 $2,840,008 $759,266 $759,266 $20,470 $7,829,513
Daniel P. Van Plew 2018 $660,000 - $677,160 $677,160 $19,915 $9,007,222
Andrew J. Murphy, Ph.D. 2020 $726,923 $5,025,288 $887,250 $887,250 $24,195 $10,998,914
Andrew J. Murphy, Ph.D. 2019 $600,000 $4,702,308 $666,900 $666,900 $23,470 $9,519,347
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/872589/000093041321000869/c101011_def14a.htm

What are Regeneron Pharmaceuticals, Inc's Past Insider Trades?

Regeneron Pharmaceuticals, Inc's most recent insider trade came on November 25, 2022 by Daniel P. van Plew who sold 50,000 units worth $37.08M . In the last 19 years, insiders at Regeneron Pharmaceuticals, Inc have sold an estimated value of $17.48B and bought an estimated value of $3.51B worth of shares. Insider trading is most common in December, with the busiest year in 2014. The most active traders at the company are Joseph L Goldstein, Director,  Michael S Brown, Director,  and P. Roy Vagelos, Director .

REGENERON PHARMACEUTICALS, INC. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1